Compare AERO & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AERO | LMAT |
|---|---|---|
| Founded | 1934 | 1983 |
| Country | Mexico | United States |
| Employees | 17068 | N/A |
| Industry | Air Freight/Delivery Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.1B |
| IPO Year | N/A | 2006 |
| Metric | AERO | LMAT |
|---|---|---|
| Price | $15.19 | $100.51 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 5 |
| Target Price | $28.57 | ★ $105.80 |
| AVG Volume (30 Days) | 287.8K | ★ 347.2K |
| Earning Date | 04-21-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.93% |
| EPS Growth | N/A | ★ 30.57 |
| EPS | N/A | ★ 0.68 |
| Revenue | N/A | ★ $249,602,000.00 |
| Revenue This Year | $11.85 | $14.21 |
| Revenue Next Year | $4.57 | $8.88 |
| P/E Ratio | ★ $7.95 | $149.54 |
| Revenue Growth | N/A | ★ 13.53 |
| 52 Week Low | $12.26 | $79.01 |
| 52 Week High | $23.05 | $118.01 |
| Indicator | AERO | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 36.13 | 54.85 |
| Support Level | $14.46 | $82.47 |
| Resistance Level | $17.17 | $114.98 |
| Average True Range (ATR) | 0.76 | 3.48 |
| MACD | -0.23 | 0.17 |
| Stochastic Oscillator | 12.85 | 55.77 |
Grupo Aeromexico SAB de CV engages in providing air transport services for passengers, goods, and cargo, as well as loyalty program services, training and management services, franchise systems commercialization, and the management of investment in shares. Its services include passenger and cargo transportation, the Club Premier loyalty program, training, charter services, and other aviation-related activities. The company operates through a single operating segment, air transportation, and its geographical presence includes both domestic and international markets, with the majority of revenue coming from the international market.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.